or Try an Advanced Search...

    Technical Analysis for BNR - Burning Rock Biotech Limited

    Grade Last Price % Change Price Change
    D 0.77 -2.53% -0.02
    BNR closed down 2.53 percent on Wednesday, May 8, 2024, on 43 percent of normal volume. It was able to find support at its 50 day moving average.
    Earnings due: May 28
    *** please verify all earnings dates ***
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Up Down
    Historical BNR trend table...
    Date Alert Name Type % Chg
    20 DMA Resistance Bearish 0.00%
    50 DMA Support Bullish 0.00%
    Gapped Down Weakness 0.00%
    Fell Below 20 DMA Bearish -2.53%
    NR7 Range Contraction -2.53%
    NR7-2 Range Contraction -2.53%
    20 DMA Support Bullish -5.30%
    NR7 Range Contraction -5.30%
    Up 3 Days in a Row Strength -5.30%
    Gapped Down Weakness -5.30%
    Older End-of-Day Signals for BNR ...

       Recent Intraday Alerts

    Alert Time
    10 DMA Resistance about 8 hours ago
    Rose Above 20 DMA about 12 hours ago
    50 DMA Support about 12 hours ago
    Rose Above 10 DMA about 12 hours ago
    Up 3% about 12 hours ago
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    BNR Chart by TradingView
    Basic chart:

    Profile

    Burning Rock Biotech develops cancer diagnostic treatment based on deoxyribonucleic acid (DNA). The company provides tumor gene detection, liquid biopsy, hereditary tumor gene detection, tumor benign, and precision clinical trail for lung cancer, breast cancer, colorectal cancer, prostatic cancer, thyroid cancer, and hereditary tumors. Burning Rock Biotech was founded in January 2014, and is based in Guangzhou, China with additional locations in Beijing and Shanghai, China.
    Classification
    Sector: Healthcare
    Industry: Diagnostics & Research
    Keywords: Medicine Cancer Clinical Medicine Acid Oncology Tumor Breast Cancer Prostate Cancer Colorectal Cancer Lung Cancer Thyroid Biopsy Thyroid Cancer Hereditary Cancers

    Is BNR a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Apr 29 Burning Rock Publishes 2023 Annual Report on Form 20-F
    Apr 26 Burning Rock Announces ADS Ratio Change
    Mar 30 Q4 2023 Burning Rock Biotech Ltd Earnings Call
    Mar 29 Burning Rock Biotech GAAP EPS of -$0.22, revenue of $17.1M
    Mar 28 Burning Rock Reports Fourth Quarter and Full Year 2023 Financial Results
    Feb 2 Here's Why Burning Rock Biotech (NASDAQ:BNR) Must Use Its Cash Wisely
    Jan 8 Sinking Burning Rock Faces De-Listing. But Could Privatization Bid Come First?
    Jan 4 Burning Rock reports receipt of Nasdaq minimum bid price notification
    Jan 4 Burning Rock Announces Receipt of Notification from NASDAQ
    Dec 20 Burning Rock Announces Results of 2023 Annual General Meeting
    See more BNR news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 2.95
    52 Week Low 0.5722
    Average Volume 48,963
    200-Day Moving Average 0.98
    50-Day Moving Average 0.77
    20-Day Moving Average 0.80
    10-Day Moving Average 0.80
    Average True Range 0.08
    RSI (14) 48.19
    ADX 13.38
    +DI 10.17
    -DI 13.66
    Chandelier Exit (Long, 3 ATRs) 0.65
    Chandelier Exit (Short, 3 ATRs) 0.91
    Upper Bollinger Bands 0.88
    Lower Bollinger Band 0.72
    Percent B (%b) 0.34
    BandWidth 20.23
    MACD Line 0.01
    MACD Signal Line 0.01
    MACD Histogram -0.004
    Fundamentals Value
    Market Cap 79.06 Million
    Num Shares 103 Million
    EPS -0.97
    Price-to-Earnings (P/E) Ratio -0.79
    Price-to-Sales 0.15
    Price-to-Book 0.73
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.87
    Resistance 3 (R3) 0.88 0.85 0.85
    Resistance 2 (R2) 0.85 0.83 0.85 0.85
    Resistance 1 (R1) 0.81 0.81 0.83 0.80 0.84
    Pivot Point 0.79 0.79 0.80 0.78 0.79
    Support 1 (S1) 0.74 0.76 0.77 0.74 0.70
    Support 2 (S2) 0.72 0.74 0.71 0.69
    Support 3 (S3) 0.68 0.72 0.69
    Support 4 (S4) 0.67